(Q30458705)
Statements
The metabotropic glutamate receptor 4-positive allosteric modulator VU0364770 produces efficacy alone and in combination with L-DOPA or an adenosine 2A antagonist in preclinical rodent models of Parkinson's disease (English)
Craig W Lindsley
P Jeffrey Conn
Colleen M Niswender
Corey R Hopkins
Ryan D Morrison
Darren W Engers
Anna L Blobaum
Kimberly Italiano
Jacob Bode
Analisa D Thompson
Jonathan W Dickerson
Nathalie Turle-Lorenzo
Thomas M Bridges
Satyawan Jadhav
J Scott Daniels
16 November 2011
1 reference
1 reference
1 reference